McKesson income statement

In fiscal 2026, McKesson reported revenue of $403.43bn, up 12.4% on the year before, operating income of $6.21bn (a 1.5% margin) and net income of $4.76bn, or $38.38 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

McKesson: income statement, annual
Fiscal year	2010Mar 2010	2011Mar 2011	2012Mar 2012	2013Mar 2013	2014Mar 2014	2015Mar 2015	2016Mar 2016	2017Mar 2017	2018Mar 2018	2019Mar 2019	2020Mar 2020	2021Mar 2021	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026	LTMJun 2026
Revenue	108.7	112.1	122.3	122.2	137.4	179.0	190.9	198.5	208.4	214.3	231.1	238.2	264.0	276.7	309.0	359.1	403.4	411.0
Cost of revenue	103.0	106.1	115.9	115.3	129.0	167.6	179.5	187.3	197.2	202.6	219.0	226.1	250.8	264.4	296.1	345.7	388.9	396.0
Gross profit	5.7	6.0	6.4	6.9	8.4	11.4	11.4	11.3	11.2	11.8	12.0	12.1	13.1	12.4	12.8	13.3	14.6	15.0
Research and development	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.3	0.1	0.1	0.1	—	—	—	—	—	—	—
Selling, general and administrative	—	—	3.7	4.1	5.4	7.9	7.4	7.4	8.1	8.4	9.2	8.8	10.5	7.8	8.7	8.5	8.1	8.2
Selling and marketing	—	0.8	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
General and administrative	1.7	1.8	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Operating income	2.0	1.8	2.1	2.3	2.4	3.0	3.5	7.1	0.8	0.9	2.5	−5.0	2.0	4.4	3.9	4.4	6.2	6.5
Interest expense	—	—	—	—	—	—	—	—	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.3
Income before tax	1.9	1.6	1.9	2.0	2.2	2.7	3.3	6.9	0.2	0.6	1.1	−5.0	1.9	4.6	3.8	4.4	6.2	6.5
Income tax	0.6	0.5	0.5	0.6	0.8	0.8	0.9	1.6	−0.1	0.4	0.0	−0.7	0.6	0.9	0.6	0.9	1.1	1.2
Net income	1.3	1.2	1.4	1.3	1.3	1.5	2.3	5.1	0.1	0.0	0.9	−4.5	1.1	3.6	3.0	3.3	4.8	4.6
Diluted EPS	$4.62	$4.57	$5.59	$5.59	$5.41	$6.27	$9.70	$22.73	$0.32	$0.17	$4.95	−$28.26	$7.23	$25.03	$22.39	$25.72	$38.38	$37.48
Diluted shares (average)	273m	263m	251m	239m	233m	235m	233m	223m	209m	197m	182m	161m	154m	142m	134m	128m	124m	123m
EBITDA	2.5	2.3	2.6	2.9	3.2	4.0	4.4	8.0	1.7	1.2	2.8	−4.7	2.4	4.7	4.2	4.7	6.5	6.8

US$ billions unless shown otherwise. Fiscal quarters.

McKesson: income statement, quarterly
Quarter	2025 Q2Sept 2024	2025 Q3Dec 2024	2025 Q4Mar 2025	2026 Q1Jun 2025	2026 Q2Sept 2025	2026 Q3Dec 2025	2026 Q4Mar 2026	2027 Q1Jun 2026
Revenue	93.7	95.3	90.8	97.8	103.2	106.2	96.3	105.4
Cost of revenue	90.4	92.0	87.2	94.5	99.6	102.5	92.3	101.7
Gross profit	3.2	3.3	3.6	3.3	3.5	3.7	4.0	3.7
Selling, general and administrative	2.5	2.0	2.0	2.2	2.1	2.0	1.8	2.3
Operating income	0.6	1.2	1.6	1.0	1.4	1.6	2.2	1.3
Interest expense	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1
Income before tax	0.5	1.2	1.5	1.1	1.4	1.6	2.1	1.3
Income tax	0.2	0.3	0.2	0.2	0.2	0.4	0.3	0.3
Net income	0.2	0.9	1.3	0.8	1.1	1.2	1.7	0.6
Diluted EPS	$1.87	$6.95	$9.92	$6.25	$8.92	$9.59	$13.65	$5.15
EBITDA	0.7	1.4	1.4	1.2	1.6	1.8	1.9	1.5

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: COR vs MCK HSIC vs MCK MCK vs YI

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from McKesson's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to McKesson.